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Whatever the branch of genome science one is part of, 
the need for data standards (more specifically, standard­
ized ways to describe an experiment) and central reposi­
tories for the huge multivariate datasets that researchers 
are  now  acquiring  seem  self­evident.  The  community 
needs to be able to reproduce analyses for key experi­
ments,  and  if  the  experimenter  is  satisfied  with  the 
quality  of  the  data,  why  should  the  data  not  be  made 
available for all?
In many ways, central repositories for data made the 
field of genome science accessible to the wider academic 
community, with over 192 complete sequenced genomes 
now  available  for  researchers  to  interrogate.  Similarly, 
moving from genome sequencing to functional genomics, 
the  Microarray  Gene  Expression  Databases  (MGED) 
society  developed  a  community­wide  agreement  on 
reporting  microarray  data  (the  Minimum  Information 
About  a  Microarray  Experiment  or  MIAME)  and,  in 
conjunction with the European Bioinformatics Institute 
(EBI)  and  the  National  Institutes  of  Health  (NIH),  the 
community  developed  databases  to  house  the 
experimental data generated by microarray experiments, 
such as The ArrayExpress Archive and the Gene Expres­
sion  Omnibus  [1,2].  It  was  no  accident  that  these 
developments occurred in parallel, because there is first a 
need to define a standard reporting language (ontology) 
before the creation of a database. As well as the ‘carrot’ of 
a community­wide resource, the MGED society was also 
incredibly  successful  at  getting  journals  on  board  to 
police the deposition of data.
The next logical extension for functional genomics after 
MIAME  was  to  extend  these  developments  from  the 
trans  criptomics community to proteomics. The Human 
Proteome  Organization  (HUPO),  an  international  con­
sor  tium of industry, academic and government scientists, 
set out to extend standard reporting to proteomics. Just 
as in the field of microarray experiments, developments 
in  data  standardization  also  led  to  the  construction  of 
repositories.  The  Proteomics  Identifications  (PRIDE) 
database is a centralized public repository for proteomic 
data. The aim of the database is to provide the proteomics 
community with the ability to store data on protein and 
peptide expression and also the associated data describ­
ing the identifications. More recently, it has expanded to 
also capture information on post­translational modifica­
tions.  PRIDE  was  developed  through  a  collaboration 
between the EBI and Ghent University, Belgium, and its 
development  has  since  been  closely  linked  with  the 
HUPO Proteomics Standardization Initiative.
So  with  transcriptomics  and  proteomics  being  such 
success stories for data standardization and deposition, it 
seemed  logical  to  extend  this  to  metabolomics.  This 
seemed to be a relatively straightforward process, given 
that  there  were  already  several  examples  of  ‘metabolic 
databases’ that contained metabolomics data in all but 
name. Before the coining of the words metabolomics and 
metabonomics there were already databases for recording 
chemical shift and coupling patterns of small molecules, 
largely  to  assist  chemists  and  biochemists  in  mixture 
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tures  [3],  and  BioMagResBank  [4],  initially  for  nuclear 
magnetic  resonance  (NMR)­determined  protein  struc­
tures, but then extended to small organic molecules and 
now encompassing metabolomic data too). Data exchange 
formats  for  NMR  datasets  are  available  from  both  the 
Collaborative  Computing  Project  for  NMR  (CCPN) 
project, which offers a data model for macromolecular 
NMR  and  related  areas,  and  the  Joint  Committee  on 
Atomic and Molecular Physical Data (JCAMP­DX) [5,6]. 
Similar developments have also occurred in mass spec­
tro  metry,  and  mass­spectrometry­based  metabolomics 
also  benefits  from  some  similarities  with  proteomic 
analyses.
Thus, following various publications on how metabo­
lomic  experiments  should  be  described  ­  such  as  the 
Minimum  Information  about  a  Metabolomics  Experi­
ment  (MIAMET)  and  Architecture  for  Metabolomics 
(ArMet)  [7],  which  were  both  written  from  a  plant 
metabolomics  perspective,  and  the  Standardization  of 
Reporting Methods for Metabolic Analysis (SMRS) [8], 
focusing  on  NMR­based  methods  and  toxicology  and 
animal functional genomics experiments ­ it seemed that 
the time was right to develop a community­wide agreed 
description of reporting a metabolomics experiment. In 
2005 two meetings were held, one in Europe through the 
EBI and the Metabolic Profiling Forum and one in the 
USA  through  the  NIH,  which  served  as  inputs  to  the 
Metabolomics Standards Initiative (MSI) that is orches­
trated by the Metabolomics Society [9]. This culminated 
with the publication of several descriptions in Metabo­
lomics, the Society’s journal, and one in Nature Biotech­
nology [10] in 2007.
However, here is where the good news begins to falter. 
Despite it being nearly 3 years since the descriptions were 
published,  there  is  still  a  very  small  number  of  actual 
studies that make their data available, and even fewer in a 
format  that  would  comply  with  the  MSI  descriptions 
[11,12]. Indeed, a quick glance across the MSI descrip­
tions  shows  that  there  is  no  unifying  description,  and 
instead a user must define first which description is most 
appropriate to them depending on what biological system 
they work on. So why is the metabolomics community 
different from other communities?
The first answer might be that it is intrinsically more 
difficult  to  describe  a  metabolomic  experiment  than  a 
transcriptomic  or  proteomic  experiment.  The  field  of 
metabolomics is dominated by two very different tech­
nologies, NMR spectroscopy and mass spectrometry, as 
well  as  a  variety  of  other  approaches,  so  producing  a 
standardized  workflow  is  difficult.  This  is  further 
complicated by the fact that many in the community do 
not  report  true  concentrations  but  rather  relative 
intensities;  in  many  cases  these  equate  to  a  relative 
concentration, but this does raise the question of how 
one compares results from an NMR spectrometer with 
those produced by a mass spectrometer.
There has also been the objection that metabolomics 
experiments are innately too difficult to explain. There 
have been many reports of relatively minor changes to 
components of an experiment producing a big change on 
the metabolome of an organism. In metabolomic studies 
in mammalian physiology this has included the effects of 
altered  batches  of  standard  chow,  the  impact  of  gut 
microflora changes from different animal facilities (even 
within the same facility but in different rooms) and even 
the impact of loud music on the urinary profiles of mice 
and rats! In an ideal world a database must capture all 
this information but clearly this is not feasible. However, 
these problems face any data standard and this will not 
just  affect  metabolomics,  but  also  be  a  problem  for 
databases from other ­omic technologies.
However,  there  are  some  positive  news  stories  from 
metabolomics.  Firstly,  although  there  is  still  a  lack  of 
community  repositories  for  data  themselves,  there  are 
databases for standard NMR and mass spectra, including 
the Human Metabolome Database [13] and the Madison 
Metabolomics Consortium Database [14]. There are also 
databases that are already in use, albeit not across the 
whole  community.  The  INTERPRET  database  [15]  has 
been used for several years to distinguish different brain 
tumors in magnetic resonance spectra collected in vivo 
and  the  COMET  database  [16]  has  demonstrated  how 
metabonomics  can  be  applied  to  the  drug  safety 
assessment  field.  Finally,  there  are  some  metabolomes 
that urgently need their own database. Although much 
effort has been expended on developing a description of 
the human metabolome [17], it is much easier to generate 
a  complete  metabolomic  description  for  some  other 
organisms.  The  yeast  metabolome  has  provided  an 
impor  tant  research  tool  for  understanding  how  the 
network of metabolism is regulated, and a large number 
of yeast mutants have also been metabolically profiled. 
Likewise, no obese Caenorhabditis elegans model seems 
to be publishable without a profile of the total fatty acids 
present,  and  thus  it  seems  a  database  of  C.  elegans 
metabolic changes associated with mutations would be a 
worthy community resource.
So what can be done? As a community we need to start 
making our data available, not just for the purposes of the 
review  process  but  in  order  to  make  the  raw  material 
accessible  for  the  next  generation  of  metabolomic 
software and bioinformatics analysis tools, which again 
can only be developed and optimized if there are data to 
work with. We also need to start to build descriptions up 
for key organisms. When manuscripts are reviewed, we 
as reviewers and editors have to start to ask to see the 
data,  if  only  to  guarantee  their  quality.  Here,  journals 
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form of suitable facilities for supplementary data and a 
stick in the form of a journal requirement for the raw 
data. However, the ultimate responsibility must lie with 
the  community.  Perhaps  the  question  is  not  what 
standards can do for you, but what you can do for data 
standards!
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